Mina Levy

1.5k total citations
18 papers, 1.3k citations indexed

About

Mina Levy is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Mina Levy has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Pharmacology. Recurrent topics in Mina Levy's work include Cancer, Hypoxia, and Metabolism (4 papers), Amino Acid Enzymes and Metabolism (3 papers) and Drug-Induced Adverse Reactions (3 papers). Mina Levy is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Amino Acid Enzymes and Metabolism (3 papers) and Drug-Induced Adverse Reactions (3 papers). Mina Levy collaborates with scholars based in United States, France and Israel. Mina Levy's co-authors include Harry Eagle, Vance I. Oyama, Ralph Fleischman, Aaron E. Freeman, Henry O. Schulze, Stanley Barban, Karl A. Piez, Andrew Freeman, Leonard A. Cohen and Robert W. Fleischman and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Mina Levy

18 papers receiving 1.1k citations

Peers

Mina Levy
Comparison fields: 5 of 103
  • Molecular Biology 525
  • Cancer Research 229
  • Pharmacology 180
  • Epidemiology 132
  • Surgery 129
Replace Ralph Fleischman with:
Ralph Fleischman United States
JoAnn Hoskins United States
Sarah G. Harris United States
K. Vosbeck Switzerland
Donald A. Clarke United States
J K Czop United States
M. Pollard United States
Chitta R. Dey United States
Marion E. Webster United States
A. Adam France
Ralph Fleischman United States View profile →
Citations per field, relative to Mina Levy
Mina Levy · 1×
Citations per year, relative to Mina Levy
Mina Levy · 1×

Countries citing papers authored by Mina Levy

Since Specialization
Citations

This map shows the geographic impact of Mina Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mina Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mina Levy more than expected).

Fields of papers citing papers by Mina Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mina Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mina Levy. The network helps show where Mina Levy may publish in the future.

Co-authorship network of co-authors of Mina Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Mina Levy. A scholar is included among the top collaborators of Mina Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mina Levy. Mina Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
# Work Indexed citations
1 34
2 38
3 36
4 22
5 95
6 30
7 179
8 231
9 37
10 288
11 14
12 4
13 9
14 184
15 4
16
On the duration of penicillin action in relation to its concentration in the serum.
20
17 26
18 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026